Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 6/2008

01-04-2008 | Case Report

Dermatological manifestations associated with microscopic polyangiitis

Authors: Shiro Niiyama, Yasuyuki Amoh, Masahiro Tomita, Kensei Katsuoka

Published in: Rheumatology International | Issue 6/2008

Login to get access

Abstract

Microscopic polyangiitis (MPA) is a systemic small vessel vasculitis, which, although primarily associated with necrotizing and crescentic glomerulonephritis and pulmonary capillaritis, often has cutaneous and musculoskeltal features. Although the skin is affected in 20–70% of patients, the precise description has been limited. This retrospective study analyzed clinical manifestations in patients of MPA with skin eruptions.
Literature
1.
Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985) Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56:467–483PubMed
2.
Dawe SA, Powell SE, Short KA, Salisbury J, Roberts J, Creamer D (2005) Microscopic polyarteritis presenting with skin necrosis in a patient with sickle-cell disease. Clin Exp Dermatol 31:60–62CrossRef
3.
Seishima M, Oyama Z, Oda M (2004) Skin eruptions associated with microscopic polyangiitis. Eur J Dermatol 14:255–258PubMed
4.
Maejima H, Shirai K, Shimamura Y, Harada H, Eto H (2004) Microscopic polyangiitis presenting urticarial erythema and Henoch-Schönlein purpura: two case reports. J Dermatol 31:655–660PubMed
5.
Akimoto S, Ishikawa O, Tsukada Y, Yano S, Miyachi Y (1997) Microscopic polyangiitis mimicking Henoch-Schönlein purpura followed by severe renal involvement: a diagnostic role for antineutrophil cytoplasmic autoantibody. Br J Dermatol 136:298–299PubMed
6.
Irvine AD, Bruce IN, Walsh MY, Bingham EA (1997) Microscopic polyangiitis delineation of a cutaneous-limited variant associated with antimyeloperoxidase autoantibody. Arch Dermatol 133:474–477PubMedCrossRef
7.
Peñas PF, Porras JI, Fraga J, Bernis C, Sarriá C, Daudén E (1996) Microscopic polyangiitis. A systemic vasculitis with a positive P-ANCA. Br J Dermatol 134:542–547PubMedCrossRef
8.
Homas PB, David-Bajar KM, Fitzpatrick JE, West SG, Tribelhorn DR (1992) Microscopic polyarteritis Report of a case with cutaneous involvement and antimyeloperoxidase antibodies. Arch Dermatol 128:1223–1228PubMedCrossRef
9.
Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B (1999) Microscopic polyangiitis clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430PubMedCrossRef
10.
Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier J-F (2000) Microscopic polyangiitis with alveolar hemorrhage A study of 29 cases and review of the literature. Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaries (GER-M”O”P). Medicine (Baltimore) 79:222–233CrossRef
Metadata
Title
Dermatological manifestations associated with microscopic polyangiitis
Authors
Shiro Niiyama
Yasuyuki Amoh
Masahiro Tomita
Kensei Katsuoka
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0497-0

Other articles of this Issue 6/2008

Rheumatology International 6/2008 Go to the issue

Original Article

The impact of clothing style on bone mineral density among women in Turkey

Original Article

Meta-analysis of the combination of TNF inhibitors plus MTX compared to MTX monotherapy, and the adjusted indirect comparison of TNF inhibitors in patients suffering from active rheumatoid arthritis

Original Article

Diastolic heart function in RA patients

Original Article

Automated neuropsychiatric measurements of information processing in fibromyalgia

Original Article

Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity

Original Article

Role of Power Doppler sonography in evaluation of therapeutic response of the knee in juvenile rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits